Beryl Drugs

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
INCOME :
Sales Turnover	12.96	15.29	11.45	13.63	13.62
Other Income	0.24	0.69	0.27	0.37	0.21
Stock Adjustments	-0.13	-0.45	0.45	0.19	-0.11
Total Income	13.07	15.53	12.17	14.19	13.72
EXPENDITURE :
Raw Materials	6.85	8.83	6.94	8.8	8.4
Excise Duty	0	0.11	0.33	0.39	0.34
Power and Fuel Cost	1.06	1.04	0.9	1.11	0.92
Other Manufacturing Expenses	0.9	0.84	1	0.69	0.82
Employee Cost	0.85	0.77	1.01	1.15	1.14
Selling and Administration Expenses	2.06	2.18	1.22	1.17	1.16
Miscellaneous Expenses	0.1	0.04	0.55	0.03	0.05
Less: Preoperative Expenditure Capitalised	0	0	0	0	0
Profit before Interest, Depreciation and Tax	1.27	1.73	0.21	0.87	0.91
Interest and Financial Charges	0.15	0.13	0.2	0.21	0.26
Profit before Depreciation and Tax	1.12	1.6	0.01	0.66	0.65
Depreciation	0.32	0.33	0.38	0.41	0.52
Profit Before Tax	0.8	1.27	-0.37	0.25	0.13
Tax	0.21	0.28	0.08	0.08	0.05
Profit After Tax	0.59	0.99	-0.45	0.17	0.08
Adjustment below Net Profit	0	0	0	0	-0.01
P and L Balance brought forward	2.01	1.02	1.47	1.35	1.28
Appropriations	0	0	0	0	0
P and L Bal. carried down	2.6	2.01	1.02	1.52	1.35
Equity Dividend	0	0	0	0	0
Preference Dividend	0	0	0	0	0
Corporate Dividend Tax	0	0	0	0	0
Equity Dividend (%)	0	0	0	0	0
Earning Per Share (Rs.)	1.16	1.95	0	0.33	0.17
Book Value	14.78	13.09	11.56	13.08	12.75
Extraordinary Items	0.01	0.36	0.01	0	0

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

INCOME :

Sales Turnover

12.96

15.29

11.45

13.63

13.62

Other Income

0.24

0.69

0.27

0.37

0.21

Stock Adjustments

-0.13

-0.45

0.45

0.19

-0.11

Total Income

13.07

15.53

12.17

14.19

13.72

EXPENDITURE :

Raw Materials

6.85

8.83

6.94

8.8

8.4

Excise Duty

0.11

0.33

0.39

0.34

Power and Fuel Cost

1.06

1.04

0.9

1.11

0.92

Other Manufacturing Expenses

0.9

0.84

0.69

0.82

Employee Cost

0.85

0.77

1.01

1.15

1.14

Selling and Administration Expenses

2.06

2.18

1.22

1.17

1.16

Miscellaneous Expenses

0.1

0.04

0.55

0.03

0.05

Less: Preoperative Expenditure Capitalised

Profit before Interest, Depreciation and Tax

1.27

1.73

0.21

0.87

0.91

Interest and Financial Charges

0.15

0.13

0.2

0.21

0.26

Profit before Depreciation and Tax

1.12

1.6

0.01

0.66

0.65

Depreciation

0.32

0.33

0.38

0.41

0.52

Profit Before Tax

0.8

1.27

-0.37

0.25

0.13

Tax

0.21

0.28

0.08

0.05

Profit After Tax

0.59

0.99

-0.45

0.17

0.08

Adjustment below Net Profit

-0.01

P and L Balance brought forward

2.01

1.02

1.47

1.35

1.28

Appropriations

P and L Bal. carried down

2.6

2.01

1.02

1.52

1.35

Equity Dividend

Preference Dividend

Corporate Dividend Tax

Equity Dividend (%)

Earning Per Share (Rs.)

1.16

1.95

0.33

0.17

Book Value

14.78

13.09

11.56

13.08

12.75

Extraordinary Items

0.01

0.36

0.01

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
SOURCES OF FUNDS :
Share Capital	5.09	5.09	5.09	5.09	5.09
Reserves and Surplus	2.43	1.57	0.79	1.57	1.4
Total Shareholders Funds	7.52	6.66	5.88	6.66	6.49
Secured Loans	1.49	0.09	0.12	1.67	1.68
Unsecured Loans	1.97	1.57	1.81	0.24	0.23
Total Debt	3.46	1.66	1.93	1.91	1.91
Total Liabilities	10.98	8.32	7.81	8.57	8.4
APPLICATION OF FUNDS :
Gross Block	2.96	2.92	9.38	8.96	8.53
Less: Accum. Depreciation	1	0.7	7.13	6.52	6.11
Net Block	1.96	2.22	2.25	2.44	2.42
Capital Work in Progress	6.24	0.08	0	0	0.24
Investments	0.48	0.22	0.49	0.68	0.68
Current Assets, Loans and Advances
Inventories	0.76	1.35	2.69	1.54	1.5
Sundry Debtors	3.44	4.83	3.06	3.58	3.7
Cash and Bank Balance	0.1	0.14	0.63	0.63	0.82
Loans and Advances	1.59	2	1.32	1.27	1.56
Less: Current Liab. and Prov.
Current Liabilities	3.57	2.49	2.54	1.47	2.41
Provisions	0.01	0.01	0.1	0.1	0.1
Net Current Assets	2.31	5.82	5.06	5.45	5.07
Miscellaneous Expenses not w/o	0	0	0	0	0
Total Assets	10.99	8.34	7.8	8.57	8.41
Contingent Liabilities	1.09	1.35	1.22	1.22	1.04

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

SOURCES OF FUNDS :

Share Capital

5.09

Reserves and Surplus

2.43

1.57

0.79

1.57

1.4

Total Shareholders Funds

7.52

6.66

5.88

6.66

6.49

Secured Loans

1.49

0.09

0.12

1.67

1.68

Unsecured Loans

1.97

1.57

1.81

0.24

0.23

Total Debt

3.46

1.66

1.93

1.91

Total Liabilities

10.98

8.32

7.81

8.57

8.4

APPLICATION OF FUNDS :

Gross Block

2.96

2.92

9.38

8.96

8.53

Less: Accum. Depreciation

0.7

7.13

6.52

6.11

Net Block

1.96

2.22

2.25

2.44

2.42

Capital Work in Progress

6.24

0.08

0.24

Investments

0.48

0.22

0.49

0.68

Current Assets, Loans and Advances

Inventories

0.76

1.35

2.69

1.54

1.5

Sundry Debtors

3.44

4.83

3.06

3.58

3.7

Cash and Bank Balance

0.1

0.14

0.63

0.82

Loans and Advances

1.59

1.32

1.27

1.56

Less: Current Liab. and Prov.

Current Liabilities

3.57

2.49

2.54

1.47

2.41

Provisions

0.01

0.1

Net Current Assets

2.31

5.82

5.06

5.45

5.07

Miscellaneous Expenses not w/o

Total Assets

10.99

8.34

7.8

8.57

8.41

Contingent Liabilities

1.09

1.35

1.22

1.04

Beryl Drugs

Enjoy Lifetime Free Delivery Trade